TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1850971

Group type: EXPERIMENTAL
Intervention: Oral acyclovir (2 g/day in three doses for 10 days)
Number of subjects: 9
Study: 7327785

Group type: EXPERIMENTAL
Intervention: Self-help manual with minimal therapist contact
Number of subjects: 31

Group type: COMPARATOR
Intervention: Therapist directed training with self-help materials plus 10 individual treatment sessions
Number of subjects: 31
Study: 30720582

Group type: EXPERIMENTAL
Intervention: SCS plus OMM
Number of subjects: 218

Group type: COMPARATOR
Intervention: OMM alone
Number of subjects: 218
Study: 28444518

Group type: EXPERIMENTAL
Intervention: Core principles video
Number of subjects: 1123

Group type: EXPERIMENTAL
Intervention: Alternative versions of a video
Number of subjects: 1123

Group type: COMPARATOR
Intervention: Information-only brochure
Number of subjects: 1123

Group type: COMPARATOR
Intervention: Information-only video
Number of subjects: 1123
Study: 27133225

Group type: EXPERIMENTAL
Intervention: DANCIN intervention (30 minutes/twice-weekly sessions for 12 weeks)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DANCIN intervention
Number of subjects: 10
Study: 24401089

Group type: EXPERIMENTAL
Intervention: Niacin/laropiprant
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 21469244

Group type: EXPERIMENTAL
Intervention: NSLP with Laryngeal Neuromonitoring (LNM)
Number of subjects: 250

Group type: COMPARATOR
Intervention: NSLP alone
Number of subjects: 250
Study: 20420058

Group type: EXPERIMENTAL
Intervention: Grandio (nano-hybrid resin composite)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Admira (Ormocer)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both Grandio and Admira
Number of subjects: 0
Study: 18074937

Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) guided biopsies
Number of subjects: 30

Group type: COMPARATOR
Intervention: Random biopsies
Number of subjects: 30
Study: 15708031

Group type: EXPERIMENTAL
Intervention: Topical application of viable bacille Calmette-Guérin (BCG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intensified BCG course (three-times-a-week for 3 consecutive weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall treatment with BCG
Number of subjects: 50
Study: 10648270

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg Ca/d as calcium carbonate, 5 d/wk for 12 months)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (5 d/wk for 12 months)
Number of subjects: 160
Study: 9309100

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus radiotherapy
Number of subjects: 318

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 318
Study: 8513854

Group type: EXPERIMENTAL
Intervention: Prednisone (PN)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prednisolone metasulfobenzoate (PO‐MS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Comparison of PN and PO‐MS
Number of subjects: 8
Study: 3545718

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g qid)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Cimetidine (400 mg bid)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Sucralfate and Cimetidine
Number of subjects: 142
Study: 31521794

Group type: EXPERIMENTAL
Intervention: Manual acupuncture (real acupuncture)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No acupuncture
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham acupuncture (manual stimulation of a needle at nonacupuncture points)
Number of subjects: 35
Study: 31766273

Group type: EXPERIMENTAL
Intervention: Egg yolk phospholipid drink containing 3 g of phospholipid bound choline
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control drink with 3 g of choline bitartrate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Egg yolk phospholipid drink
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control drink with choline bitartrate
Number of subjects: 18
Study: 28653872

Group type: EXPERIMENTAL
Intervention: BML volume in the proximal tibia and distal femur
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Larger medial tibiofemoral BML volume
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Larger lateral tibiofemoral BML volume
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: BML volume
Number of subjects: 121
Study: 24673380

Group type: EXPERIMENTAL
Intervention: Percentage of poor residents in a student's neighborhood
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Percentage of black residents in the neighborhood (for children of single parents)
Number of subjects: 298
Study: 23477701

Group type: EXPERIMENTAL
Intervention: Psychological intervention including support, empathy, education, and desensitization in the NP group
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Psychological intervention including support, empathy, education, and desensitization in the FM group
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (CG) with no intervention
Number of subjects: 65
Study: 21986981

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Airtraq video laryngoscope
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pentax AWS video laryngoscope
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Glidescope Ranger video laryngoscope
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: McGrath Series 5 video laryngoscope
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Storz C-MAC video laryngoscope
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Airtraq and Ambu Pentax AWS
Number of subjects: 25
Study: 19324491

Group type: EXPERIMENTAL
Intervention: Total laparoscopic hysterectomy (TLH)
Number of subjects: 0
Study: 16937475

Group type: EXPERIMENTAL
Intervention: Standard triple therapy (20 mg omeprazole b.i.d., 1000 mg amoxicillin b.i.d., 500 mg clarithromycin b.i.d.)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Standard quadruple therapy (20 mg omeprazole b.i.d., 1000 mg amoxicillin b.i.d., 240 mg colloidal bismuth subcitrate b.i.d., and 500 mg metronidazole b.i.d.)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam-based quadruple therapy (375 mg sultamicillin b.i.d.)
Number of subjects: 360
Study: 15319615

Group type: EXPERIMENTAL
Intervention: Interviewer-administered telephone surveys
Number of subjects: 479

Group type: COMPARATOR
Intervention: Self-administered mail surveys with telephone reminder calls
Number of subjects: 479

Group type: COMPARATOR
Intervention: Self-administered mail surveys
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Both modes of survey administration
Number of subjects: 479
Study: 11173173

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine tablets
Number of subjects: 58

Group type: COMPARATOR
Intervention: Oral methadone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study: 9015032

Group type: EXPERIMENTAL
Intervention: hCG levels in vaginal fluid for normal pregnant women during the first trimester
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: hCG levels in vaginal fluid for normal pregnant women during the second trimester
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: hCG levels in vaginal fluid for normal pregnant women during the third trimester
Number of subjects: 188

Group type: COMPARATOR
Intervention: hCG levels in vaginal fluid for women with confirmed PROM
Number of subjects: 188
Study: 8328376

Group type: EXPERIMENTAL
Intervention: 8-week rehabilitation intervention
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 201
Study: 3828177

Group type: EXPERIMENTAL
Intervention: Laryngoscopy with intubation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Laryngoscopy only
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (Laryngoscopy with and without intubation)
Number of subjects: 24
Study: 28188570

Group type: EXPERIMENTAL
Intervention: Survey study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized behavioral intervention study
Number of subjects: 0
Study: 26268935

Group type: EXPERIMENTAL
Intervention: Leflunomide 50 mg/week (LEF50)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Leflunomide 10 mg/day (LEF10)
Number of subjects: 244
Study: 26632713

Group type: EXPERIMENTAL
Intervention: Semirigid synthetic softcast
Number of subjects: 196

Group type: COMPARATOR
Intervention: Plaster of Paris (POP) cast
Number of subjects: 196
Study: 22727972

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 105

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 105
Study: 22028220

Group type: EXPERIMENTAL
Intervention: IV tPA
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 18440250

Group type: EXPERIMENTAL
Intervention: Subintimal angioplasty (SA)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 146
Study: 16995975

Group type: EXPERIMENTAL
Intervention: ALSS treatment
Number of subjects: 518
Study: 12893079

Group type: EXPERIMENTAL
Intervention: Unilateral neck RT with parotid-sparing techniques
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Bilateral neck RT with parotid-sparing techniques
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard three-field technique RT
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Lower radiation dose to contralateral parotid glands
Number of subjects: 93
Study: 10860694

Group type: EXPERIMENTAL
Intervention: Connecta Clave(R) (CC(R))
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group with standard entry port caps
Number of subjects: 173
Study: 7720142

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (GH) 0.2 IU/kg/d
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2736966

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 16
Study: 4924346

Group type: EXPERIMENTAL
Intervention: U.K. 2371
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study: 31729933

Group type: EXPERIMENTAL
Intervention: TAU plus aerobic exercise training (EX)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: TAU and EX (both groups)
Number of subjects: 21
Study: 31050004

Group type: EXPERIMENTAL
Intervention: Straight and spiral leads using distal electrode
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Straight and spiral leads from at least one of the proximal (E2-E4) electrodes
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Unipolar vectors
Number of subjects: 795

Group type: COMPARATOR
Intervention: Bipolar vectors
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Capture thresholds
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Capture thresholds over a mean follow-up of 1 year
Number of subjects: 795
Study: 29798127

Group type: EXPERIMENTAL
Intervention: Ketotifen 1 mg 2 times/day oral treatment
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group treatment (antitussive, expectorant, and inhaled corticosteroids)
Number of subjects: 42
Study: 26245802

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 215

Group type: COMPARATOR
Intervention: PMA-induced NET formation
Number of subjects: 215

Group type: COMPARATOR
Intervention: CpG-stimulated PDC IFNα generation
Number of subjects: 215
Study: 23684588

Group type: EXPERIMENTAL
Intervention: Interstitial brachytherapy (ISBT) combined with interstitial hyperthermia (ISHT)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Interstitial brachytherapy (ISBT) alone
Number of subjects: 205
Study: 21620644

Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 20% oral sucrose
Number of subjects: 165

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 165
Study: 19033369

Group type: EXPERIMENTAL
Intervention: Elagolix (50-200 mg daily or 100 mg twice daily for 7 days)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Elagolix (single oral dose of 25-400 mg)
Number of subjects: 55
Study: 17690999

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 15385103

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin 50 mg/m² every 28 days
Number of subjects: 474

Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m² per day for 5 days every 21 days
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin 50 mg/m² every 28 days (for platinum-sensitive disease)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m² per day for 5 days every 21 days (for platinum-sensitive disease)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Pegylated liposomal doxorubicin 50 mg/m² every 28 days (for all randomized subjects)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m² per day for 5 days every 21 days (for all randomized subjects)
Number of subjects: 474
Study: 11216984

Group type: EXPERIMENTAL
Intervention: Anomalous origins of the left main coronary artery (ALMCA)
Number of subjects: 2388

Group type: EXPERIMENTAL
Intervention: Anomalous origins of the right coronary artery (ARCA)
Number of subjects: 2388

Group type: COMPARATOR
Intervention: Echocardiography
Number of subjects: 2388
Study: 11907946

Group type: EXPERIMENTAL
Intervention: 1 mg E2/0.25 mg NETA
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 1 mg E2/0.5 mg NETA
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 7673613

Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg once daily for 8 weeks
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg once daily for 8 weeks
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg once daily for 6 weeks
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg once daily for 6 weeks
Number of subjects: 86
Study: 2285093

Group type: EXPERIMENTAL
Intervention: Neoprene insoles
Number of subjects: 1388

Group type: COMPARATOR
Intervention: Control group (no insoles)
Number of subjects: 1388
Study: 7447829

Group type: EXPERIMENTAL
Intervention: Metrizamide 280 mg/ml
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metrizamide 180 mg/ml
Number of subjects: 0
Study: 31504624

Group type: EXPERIMENTAL
Intervention: Strengths and Difficulties Questionnaire in Norwegian Sign Language (SDQ-NSL)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Strengths and Difficulties Questionnaire in written Norwegian (SDQ-NOR)
Number of subjects: 49
Study: 31154315

Group type: EXPERIMENTAL
Intervention: Coping intervention for recurrent miscarriage (details not specified)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 14
Study: 28886907

Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 14215

Group type: COMPARATOR
Intervention: qHPV vaccine (control)
Number of subjects: 14215
Study: 26355492

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 200

Group type: COMPARATOR
Intervention: PRO-Breathe
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: i-gel size 1.5
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: i-gel size 2
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: i-gel size 2.5
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: i-gel size 3
Number of subjects: 200
Study: 24108790

Group type: EXPERIMENTAL
Intervention: Calibrated RQ estimates using 4-day food record (4DFR) data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calibrated RQ estimates using food-frequency data
Number of subjects: 0
Study: 21420586

Group type: EXPERIMENTAL
Intervention: Topical diclofenac 0.1% applied 2 hours before PRK
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo applied 2 hours before PRK
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Topical diclofenac 0.1% applied every 6 hours for 2 days postoperatively
Number of subjects: 70
Study: 19208729

Group type: EXPERIMENTAL
Intervention: Fructose-sweetened beverages
Number of subjects: 17

Group type: COMPARATOR
Intervention: Glucose-sweetened beverages
Number of subjects: 17
Study: 17306936

Group type: EXPERIMENTAL
Intervention: Shorter interfraction interval (IFI) of 4.5-5.0 hours (n = 52)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Longer interfraction interval (IFI) of 5.5-6.0 hours (n = 51)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Shorter IFI
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Longer IFI
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: All patients (n = 103)
Number of subjects: 103
Study: 15330012

Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulative therapy (SMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11166750

Group type: EXPERIMENTAL
Intervention: Mantoux test
Number of subjects: 300
Study: 9560871

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Stress Management (CBSM) group intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 40
Study: 7751567

Group type: EXPERIMENTAL
Intervention: PCR technique for detection of Shigella and EIEC
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy with PCR detection after 3 days
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy with PCR detection after 7 days
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard microbiological methods
Number of subjects: 119
Study: 2839019

Group type: EXPERIMENTAL
Intervention: enalapril (2.5 to 40 mg/day)
Number of subjects: 253

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 253
Study: 31647001

Group type: EXPERIMENTAL
Intervention: Teach-back communication strategy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard medical consultation (control)
Number of subjects: 70
Study: 28877891

Group type: EXPERIMENTAL
Intervention: Fat-free mass
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Fasting prospective food consumption ratings and RMR
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: RMR
Number of subjects: 191
Study: 25740979

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 492

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 492
Study: 23621808

Group type: EXPERIMENTAL
Intervention: Bisphosphonate-coated pins in the tibial shaft
Number of subjects: 20

Group type: COMPARATOR
Intervention: Uncoated pins in the tibial shaft
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bisphosphonate-coated pins in the metaphysis
Number of subjects: 20

Group type: COMPARATOR
Intervention: HA-coated pins in the metaphysis
Number of subjects: 20
Study: 20176450

Group type: EXPERIMENTAL
Intervention: d‐amphetamine (20mg)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Stressful task (public speech)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-stressful control task
Number of subjects: 34
Study: 18209133

Group type: EXPERIMENTAL
Intervention: Cochlear implant activated (on)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cochlear implant deactivated (off)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (normal hearing)
Number of subjects: 41
Study: 16545724

Group type: EXPERIMENTAL
Intervention: Once-daily filgrastim at 400 microg/m(2)/d
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Twice-daily filgrastim at 400 microg/m(2)/d
Number of subjects: 72

Group type: COMPARATOR
Intervention: Both groups (O and T)
Number of subjects: 72
Study: 14615662

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) prophylaxis
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) prophylaxis (low viral load)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) prophylaxis (high viral load)
Number of subjects: 250
Study: 11049884

Group type: EXPERIMENTAL
Intervention: Sevoflurane with ondansetron
Number of subjects: 180

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 180

Group type: COMPARATOR
Intervention: Sevoflurane alone
Number of subjects: 180
Study: 8659426

Group type: EXPERIMENTAL
Intervention: CAST with 150 ml of contrast material
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: CAST with 125 ml of contrast material
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: CAST with 100 ml of contrast material
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control with 150 ml of contrast material
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control with 100 ml of contrast material
Number of subjects: 183
Study: 1389714

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hydralazine plus isosorbide mononitrate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no vasodilator)
Number of subjects: 8
Study: 3908884

Group type: EXPERIMENTAL
Intervention: Oestriol 3 mg daily for 3 months
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 30683710

Group type: EXPERIMENTAL
Intervention: CBT mobile app for anxiety
Number of subjects: 145

Group type: COMPARATOR
Intervention: Health education program (control)
Number of subjects: 145
Study: 29384318

Group type: EXPERIMENTAL
Intervention: High eating frequency (HEF) meals at 08:00, 10:00, 12:00, 15:00, 18:00 and 20:00 h
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal eating frequency (NEF) meals at 08:00, 12:00 and 18:00 h
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High eating frequency (HEF)
Number of subjects: 70
Study: 27061066

Group type: EXPERIMENTAL
Intervention: Selegiline+Rotigotine
Number of subjects: 130

Group type: COMPARATOR
Intervention: Selegiline+Placebo
Number of subjects: 130
Study: 24625044

Group type: EXPERIMENTAL
Intervention: Memory training using the method of loci (MoL)
Number of subjects: 1401

Group type: COMPARATOR
Intervention: Control group (no MoL training)
Number of subjects: 1401
Study: 22133660

Group type: EXPERIMENTAL
Intervention: AG200‐15
Number of subjects: 36
Study: 20658006

Group type: EXPERIMENTAL
Intervention: Laser therapy (AsGaAl laser, 40mW power, 80J/cm² for 16 seconds at four selected points, one session)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 50